BioStock: Cereno Scientific solidifies CS1 patent protection in Japan

At the end of 2021, Cereno Scientific obtained its first patent in the third patent family associated with lead cardiovascular disease drug candidate CS1. That patent was granted for the Russian market, and, last week, Cereno announced extending this patent family's protection to Japan.

Read the article at biostock.se:

https://www.biostock.se/en/2022/01/cereno-scientific-solidifies-cs1-patent-protection-in-japan/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se